mesalamine has been researched along with Disease, Pulmonary in 17 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present three patients with ulcerative colitis, all treated with mesalazine, in whom unexplained lung disease developed." | 2.50 | Pulmonary pathology in patients with ulcerative colitis treated with mesalazine--a challenging and complex diagnostic problem. Case series and literature review. ( Bestry, I; Kacprzak, A; Kuś, J; Langfort, R; Siemion-Szcześniak, I; Szturmowicz, M, 2014) |
| "Due to the frequency of preceding pulmonary disease and the common temporal dissociation regarding intestinal disease, pulmonary manifestations of inflammatory bowel disease are at high risk of being overlooked." | 2.46 | [Pulmonary manifestations of inflammatory bowel disease]. ( Bachmann, O; Länger, F; Rademacher, J, 2010) |
| "A 75-year-old female was diagnosed with ulcerative colitis and took mesalazine over a period of 2 years and 8 months." | 1.48 | Mesalazine-related lung disease in a patient with ulcerative colitis: A case report. ( Cheng, YM; Chiu, CT; Hu, HC; Huang, PH; Kuo, CJ; Lin, CW; Lin, CY; Su, MY, 2018) |
| "A 51-year-old woman diagnosed with Crohn's disease developed drug-induced hypersensitivity syndrome (DIHS) 12 and six weeks after starting the oral intake of mesalazine and trimethoprim/sulfamethoxazole, respectively." | 1.43 | Drug-induced Hypersensitivity Syndrome Accompanied by Pulmonary Lesions Exhibiting Centrilobular Nodular Shadows. ( Bando, M; Kogawara, H; Mato, N; Nakayama, M; Sawata, T; Sugiyama, Y; Takemura, T; Yamasawa, H, 2016) |
| "Of 12 patients with active ulcerative colitis (UC), 4 patients were without treatment, 4 were on prednisone and 4 on mesalazine." | 1.29 | Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis. ( Agostini, D; Boirivant, M; Corsi, A; D'Ambrosio, C; Letizia, C; Pallone, F; Scavo, D, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirakawa, H | 1 |
| Tashiro, H | 1 |
| Takahashi, K | 1 |
| Tanaka, M | 1 |
| Sadamatsu, H | 1 |
| Kimura, S | 1 |
| Sueoka-Aragane, N | 1 |
| Huang, PH | 1 |
| Kuo, CJ | 1 |
| Lin, CW | 1 |
| Cheng, YM | 1 |
| Hu, HC | 1 |
| Lin, CY | 1 |
| Su, MY | 1 |
| Chiu, CT | 1 |
| Kacprzak, A | 1 |
| Siemion-Szcześniak, I | 1 |
| Szturmowicz, M | 1 |
| Bestry, I | 1 |
| Langfort, R | 1 |
| Kuś, J | 1 |
| Sawata, T | 1 |
| Bando, M | 1 |
| Kogawara, H | 1 |
| Nakayama, M | 1 |
| Mato, N | 1 |
| Yamasawa, H | 1 |
| Takemura, T | 1 |
| Sugiyama, Y | 1 |
| Shimizu, T | 1 |
| Hayashi, M | 1 |
| Shimizu, N | 1 |
| Kinebuchi, S | 1 |
| Toyama, J | 1 |
| Bachmann, O | 1 |
| Länger, F | 1 |
| Rademacher, J | 1 |
| Akpınar, EE | 1 |
| Gülhan, M | 1 |
| Değertekin, H | 1 |
| Ataoğlu, Ö | 1 |
| Lachaine, J | 1 |
| Yen, L | 1 |
| Beauchemin, C | 1 |
| Hodgkins, P | 1 |
| Radwan, P | 1 |
| łupina, T | 1 |
| Radwan-Kwiatek, K | 1 |
| Milanowski, J | 1 |
| Honeybourne, D | 1 |
| Letizia, C | 1 |
| D'Ambrosio, C | 1 |
| Agostini, D | 1 |
| Corsi, A | 1 |
| Boirivant, M | 1 |
| Pallone, F | 1 |
| Scavo, D | 1 |
| Bitton, A | 1 |
| Peppercorn, MA | 1 |
| Hanrahan, JP | 1 |
| Upton, MP | 1 |
| Sesin, GP | 1 |
| Mucciardi, N | 1 |
| Almeida, S | 1 |
| Guslandi, M | 1 |
| Facchini, S | 1 |
| Candusso, M | 1 |
| Zennaro, F | 1 |
| Ventura, A | 1 |
| Faller, M | 1 |
| Gasser, B | 1 |
| Massard, G | 1 |
| Pauli, G | 1 |
| Quoix, E | 1 |
| Reinoso, MA | 1 |
| Schroeder, KW | 1 |
| Pisani, RJ | 1 |
3 reviews available for mesalamine and Disease, Pulmonary
| Article | Year |
|---|---|
Pulmonary pathology in patients with ulcerative colitis treated with mesalazine--a challenging and complex diagnostic problem. Case series and literature review.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Lung Dise | 2014 |
[Pulmonary manifestations of inflammatory bowel disease].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Bronchoscopy; Chest Pain; Colitis, Ulcerative; Cough; | 2010 |
Mesalamine-induced lung toxicity.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; H | 1996 |
14 other studies available for mesalamine and Disease, Pulmonary
| Article | Year |
|---|---|
Mesalazine-induced airway obstruction: Utility of pulmonary function testing in drug-induced lung diseases.
Topics: Humans; Lung Diseases; Mesalamine; Respiratory Function Tests | 2019 |
Mesalazine-related lung disease in a patient with ulcerative colitis: A case report.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diagnosis, Differential; Female; | 2018 |
Drug-induced Hypersensitivity Syndrome Accompanied by Pulmonary Lesions Exhibiting Centrilobular Nodular Shadows.
Topics: Crohn Disease; Drug Combinations; Drug Hypersensitivity Syndrome; Female; Humans; Lung; Lung Disease | 2016 |
[A case of mesalazine-induced lung injury improved by only discontinuation of mesalazine].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Lung Diseases; Mesalam | 2009 |
Thorax as an extraintestinal target for inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Inflammatory Bowel Diseases; Lung Diseases; | 2011 |
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Canada; Coliti | 2013 |
[Pulmonary complications in patient with ulcerative colitis, treated with 5-aminosalicylic preparations].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Humans; Lung | 2006 |
Mesalazine toxicity.
Topics: Adult; Aminosalicylic Acids; Female; Humans; Lung Diseases; Mesalamine | 1994 |
Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Co | 1993 |
Mesalamine-associated pleural effusion with pulmonary infiltration.
Topics: Aged; Colitis, Ulcerative; Female; Humans; Lung Diseases; Mesalamine; Pleural Effusion | 1998 |
Respiratory distress during mesalamine therapy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Lung Diseases; | 1999 |
Clinical quiz. 5-ASA hypersensitivity lung disease.
Topics: Adolescent; Antibodies, Antineutrophil Cytoplasmic; Colitis, Ulcerative; Drug Hypersensitivity; Huma | 1999 |
Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Eosinophilia; Female; Humans; Lung; L | 2000 |
Lung disease associated with orally administered mesalamine for ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Lung Diseases; Mesa | 1992 |